Thought Leadership - Spherix Global Insights

Invest in intelligence that delivers

Spherix Thought Leadership

From conference presentations to white papers and other publicly shared research, access a comprehensive collection to stay informed and drive impactful decisions.

Dermatology

Understand the remaining unmet need in plaque psoriasis and to uncover early perceptions of the oral small molecules in development for plaque psoriasis.

Cross Speciality

Discussion on the Inflation Reduction Act During the Healthcare Businesswomen's Association Virtual Event

Dermatology

Earlier Diagnosis and Treatment: The Key to Better Outcomes in Hidradenitis Suppurativa

Rheumatology

Chart Audit of Over 1,000 SLE Patients Reveals Biologic Treatment Choice Driven by Disease Manifestations

Rheumatology

Not Yet on Track: Retrospective Chart Analysis Reveals Physician’s Treatment Approaches in SLE Fall Short of New EULAR Guidance

Nephrology

A Complement and B-Cell Modifying Pipeline to Address Unmet Needs in IgA Nephropathy (IgAN)

Nephrology

A Comparative View of Early Career and Established Nephrologist Perspectives

Nephrology

The Untapped Potential of the ADPKD Treatment Landscape

Dermatology

Acceptable Clinical Trial Differences vs Placebo in Plaque Psoriasis

Dermatology

Uptake of Secukinumab in Hidradenitis Suppurativa

Neurology

A KOL Perspective: Exclusive Interview with Dr. Naismith

Rheumatology

Specialists' Comfort with Cutaneous Lupus Erythematosus Reveals Potential Gaps and a Need for Co- Management Strategies

Nephrology

Evolution of Treatment Paradigms in Diabetic Kidney Disease

Neurology

Characterization of Early Adopters of SC FcRn Blockers for gMG

Rheumatology

Amplifying the Lupus Patient Voice: Insights into the Diagnostic Journey and Informational Needs

Nephrology

The Meteoric Rise of SGLT2 Inhibitors in Glomerular Diseases

Nephrology

Genetic Testing in Patients with Focal Segmental Glomerulosclerosis

Nephrology

A Comparative View of IgA Nephropathy Care Across Four Global Regions

Nephrology

Shifts in SGLT2 Inhibitor Initiation in CKD Non-Dialysis Patients

Nephrology

Uncovering the Potential of HIF-PH Inhibitors to Treat Renal Anemia

Neurology

The Uptake of Relyvrio™ (sodium phenylbutyrate and taurursodiol) in ALS among General Neurologists Compared to Neuromuscular Specialists and to ALS Center Affiliated Neurologists

Media

Sanofi Garners Highest Physician Interest in Asthma Pipeline, Despite GSK’s Later-Stage Asset, According to Spherix Global Insights

May 13, 2025

Emerging Treatments Drive Notable Changes in IgA Nephropathy Care Across Key Global Markets, According to Spherix Global Insights

May 8, 2025

Gene Therapy Momentum Builds Among Hematologists in Sickle Cell Disease Management Despite Ongoing Access Barriers, According to Spherix Global Insights

May 1, 2025

Specialists Eye Gazyva as a New Option for Lupus Nephritis, but ACR Guidelines Favor Benlysta and Lupkynis for Upfront Use, According to Spherix Global Insights

April 30, 2025

Talk to an expert

Andy Stankus
Franchise Head, Dermatology

Jim Hickey
Franchise Head, Gastroenterology

Andy Stankus
Franchise Head, Rheumatology

Tucker Hurtado
Franchise Head, Nephrology

Bob Shewbrooks
Franchise Head, Neurology

Bob Shewbrooks
Franchise Head, Ophthalmology

Sarah Hendry
Franchise Head, Hematology